Full Press Release Details
ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter.
Information about the Company’s quarterly results, conference calls, webcasts and other investor information is available in the Investors section of the Company’s website.
About Clearside Biomedical, Inc.
Investor and Media Contacts:
Source: Clearside Biomedical, Inc.